good stuff aware head weekend ahrp notes fda review panel examine risks associated merck new cox inhibitor etoricoxib arcoxia stacked find drug safe well ahrp said arthritis specialists voted keep cox inhibitors market reappointed four vocal critics cox pain killers reappointed fda apparently wants avoid full examination safety issues considering approval merck vioxx replacement drug good news exception one member hell one member arcoxia got voted margin gooznews great post mentions advisory committee decided getting fooled twice option david graham unsurprisingly stepped plate yet incredibly merck decided compare arcoxia another drug elevated risk causing heart problems irb approved study comparing risky drug merck could attempt claim arcoxia increase cardiovascular risk like comparing drug getting hit sledgehammer well drug actually less risky brained large blunt object therefore clearly safe nice see fda fall time pharmalot also nice summary arcoxia debacle surprise pharma giles guilty causing me nearly suffer fate took ill fated drug uleak due def comedy jam type laughter two recent posts one uleak one thinly disguised parody latest developments astrazeneca peter rost received information allegedly astra zeneca insider stating tired az unethical practices specifically referencing marketing arimidex anastrozole seroquel far behind i also give dr rost credit applying positions drug industry read hilarious accurate cover letter philip dawdy notes yet another class action lawsuit filed lilly heavy pimping zyprexa seroxat secrets points another example patient advocacy groups carrying big pharma water case appears depression alliance participating marketing cymbalta cymbalta pimp thon continues